NSE
Ajooni Biotech LimitedAJOONI
Ajooni Biotech Limited is an Indian biotechnology company focused on developing and commercializing innovative healthcare solutions.
| Key products | Biopharmaceuticals, diagnostics |
|---|---|
| Geography | India |
| Competitors | Biocon Ltd., Dr. Reddy's Laboratories |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Annual General Meeting
ex 2024-09-10
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹5.2 Cr | 159 | — | — | — | — |
| 2 | MOBIKWIK | +₹0.1 Cr | 83 | — | — | — | — |
| 3 | QUADFUTURE | +₹0 Cr | 134 | — | — | — | — |
| 4 | AJOONIThis | — | — | — | — | — | — |
| 5 | MTNL | +₹0 Cr | 2 | — | — | — | — |
| 6 | GATECH | +₹0 Cr | 8 | — | — | — | — |
| 7 | IRMENERGY | −₹2.2 Cr | 328 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- • Developing innovative vaccines for infectious diseases
- • Strong pipeline of biopharmaceutical products
- • Growing presence in the Indian pharmaceutical market
Weaknesses
- • Dependence on a limited number of products and revenue streams
- • High research and development expenses
- • Competition from established players like Biocon Ltd.
Opportunities
- • Increasing demand for vaccines and biopharmaceuticals due to growing healthcare needs in India
- • Partnerships with international companies to expand product portfolio
- • Growing focus on personalized medicine and genomics
Threats
- • Regulatory challenges and changes in government policies affecting the pharmaceutical industry
- • Competition from generic drugs and biosimilars
- • Global health crises and pandemics impacting demand for biopharmaceuticals
AI-generated from our data — verify before relying on it.
- 2025-01-02BulkBUY · ₹0.6 CrNEO APEX VENTURE LLP
- 2025-01-02BulkSELL · ₹0.9 CrNEO APEX VENTURE LLP
- 2025-01-02NetDay net −₹0.3 Cr
- 2024-09-10ActionAnnual General MeetingMeeting
- 2024-08-30BulkSELL · ₹0.8 CrSHUBHAM KUMAR
- 2024-08-30BulkBUY · ₹0.8 CrSHUBHAM KUMAR
- 2024-08-30NetDay net −₹0 Cr
- 2024-07-26BulkBUY · ₹0.6 CrGADARA POONAM
- 2024-07-26NetDay net +₹0.6 Cr
- 2024-07-09BulkSELL · ₹0.8 CrPUNJAB BIOTECHNOLOGY PARK LIMITED
- 2024-07-09BulkBUY · ₹1 CrJASPAL SINGH BINDRA
- 2024-07-09BulkSELL · ₹0.8 CrGAYATRIBEN NISHANT SHAH
- 2024-07-09BulkBUY · ₹0.8 CrGAYATRIBEN NISHANT SHAH
- 2024-07-09NetDay net +₹0.2 Cr
- 2024-07-03BulkSELL · ₹1 CrSUSHILA GAUTAMLAL KALAL
- 2024-07-03BulkBUY · ₹1 CrSUSHILA GAUTAMLAL KALAL
- 2024-07-03BulkBUY · ₹1.7 CrPRASHANT GUPTA
- 2024-07-03BulkSELL · ₹1.7 CrPRASHANT GUPTA
- 2024-07-03BulkBUY · ₹0.7 CrNATVARSINH T CHAVDA
- 2024-07-03BulkSELL · ₹0.5 CrNATVARSINH T CHAVDA
- 2024-07-03BulkSELL · ₹1.2 CrBHUMIKABEN SUNILBHAI PATEL
- 2024-07-03BulkSELL · ₹0.6 CrACHINTYA SECURITIES PRIVATE LIMITED
- 2024-07-03BulkBUY · ₹0.6 CrACHINTYA SECURITIES PRIVATE LIMITED
- 2024-07-03NetDay net −₹0.9 Cr
- 2024-07-02BulkSELL · ₹1.1 CrBHUMIKABEN SUNILBHAI PATEL
- 2024-07-02NetDay net −₹1.1 Cr
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
No scored filings for AJOONI yet.
19 deals · 2024-07-02 → 2025-01-02
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-01-02 | NEO APEX VENTURE LLP | HNI / other | BUY | ₹0.6 Cr |
| 2025-01-02 | NEO APEX VENTURE LLP | HNI / other | SELL | ₹0.9 Cr |
| 2024-08-30 | SHUBHAM KUMAR | HNI / other | SELL | ₹0.8 Cr |
| 2024-08-30 | SHUBHAM KUMAR | HNI / other | BUY | ₹0.8 Cr |
| 2024-07-26 | GADARA POONAM | HNI / other | BUY | ₹0.6 Cr |
| 2024-07-09 | PUNJAB BIOTECHNOLOGY PARK LIMITED | HNI / other | SELL | ₹0.8 Cr |
| 2024-07-09 | JASPAL SINGH BINDRA | HNI / other | BUY | ₹1 Cr |
| 2024-07-09 | GAYATRIBEN NISHANT SHAH | HNI / other | SELL | ₹0.8 Cr |
| 2024-07-09 | GAYATRIBEN NISHANT SHAH | HNI / other | BUY | ₹0.8 Cr |
| 2024-07-03 | SUSHILA GAUTAMLAL KALAL | HNI / other | SELL | ₹1 Cr |
19 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on AJOONI
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.